ZBH - Zimmer Value Adjusted for Debt and Cash

Brandmark of Zimmer Biomet Holdings Inc (ZBH)

The price history of Zimmer Biomet Holdings (ZBH), where the Enterprise Value stands at 25106.22, reflects the business development of robotic systems and joint prosthetics. Growth metrics are driven by the implementation of mixed reality and the launch of "smart" implants. The brand's high standing among physicians confirms the impeccable quality of products that restore mobility to patients.

Total Company Value: Zimmer (ZBH) for 11/23/2025 - 10/31/2026

Zimmer Biomet Corp (ZBH) - metric breakdowns and financial figures

- stock price and consensus target price:
Price Chart Zimmer Biomet Holdings, Inc.|ZBH - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Zimmer Biomet|ZBH - Total Company Value
- book capitalization information:
Net Assets per Share Zimmer Biomet|ZBH - Company Book Value|Market Capitalization to Net Assets zimmerbiomet.com|ZBH - Company Total Assets
- debt level and financial liquidity data:
Debt to Capital Zimmer Biomet Holdings|ZBH - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Zimmer|ZBH - Company Aggregate Debts|Debts to Net Assets Zimmer Biomet|ZBH - Company Long-Term Debts|Company Short-Term Debts Zimmer Biomet|Quick Liquidity zimmerbiomet.com
- company profitability and valuation multiples indicators:
ZBH - Net Profit
Summary company analytics:ZBH zimmerbiomet.com
Manufactured product of Zimmer Biomet Holdings

Enterprise value determines the investment attractiveness of Zimmer Biomet Holdings (ZBH), summing market capitalization and debt obligations minus liquid assets to calculate the actual business acquisition price. By analyzing the enterprise value chart, an investor can see the capitalization of technological leadership in orthopedics, where high surgeon loyalty to implants ensures valuation stability even under strict healthcare budget controls.

Who Zimmer Biomet Holdings competes with

Boston Scientific Corp - Total Company Value|Edwards Lifesciences Corp - Enterprise Value|Value Adjusted for Debt and Cash RMD (ResMed Corporation)|Insulet Corporation (PODD) - Total Company Value|COO - Company Buyout Price|Total Company Value Align Technology|Globus Medical Inc - Full Business Value|Enterprise Value TMDX|ATEC - Total Enterprise Value|Enterprise Value AORT (Artivion, Inc.)|ENOV - Real Price to Acquire Entire Company|Integra LifeSciences Holdings Corporation - Enterprise Value|Company Buyout Price Establishment Labs Corp ESTA|BBNX: Enterprise Value|IRADIMED Inc. (IRMD) - Enterprise Value|Total Company Value Embecta Corp.|Total Company Value TNDM|Enterprise Value AXGN|Company Buyout Price SI-BONE Inc|Orthofix International - Real Price to Acquire Entire Company|BVS (Bioventus Global) - Full Business Value|OrthoPediatrics Inc. - Enterprise Value|Total Enterprise Value treace.com|SRTA: Enterprise Value|Business Value CARL|Real Price to Acquire Entire Company RXST|CLPT: Value Adjusted for Debt and Cash|Total Company Value Stereotaxis, Inc. (STXS)|Real Price to Acquire Entire Company neurostar.com STIM|Enterprise Value SGHT (Sight Sciences)|orchestrabiomed.com (OBIO) - Total Enterprise Value|Anika - Enterprise Value|NSPR (InspireMD Inc.) - Business Value|ZJYL: Enterprise Value|VANI - Company Buyout Price|XTNT (Xtant Medical Holdings, Inc.) - Enterprise Value|Real Price to Acquire Entire Company NeuroOne (NMTC)|Enterprise Value MODD|Enterprise Value Myomo Inc (MYO)|Total Company Value Envoy Medical, Inc. COCH|vivoslife.com - Total Company Value|NVNO: Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash SINT (Sintx Technologies)|TNON: Enterprise Value|Total Enterprise Value Lifeward Ltd. (LFWD)|Total Company Value Autonomix Medical Inc.|IVF - Full Takeover Company Value|Real Price to Acquire Entire Company BBLG (Bone Biologics Corp)|Enterprise Value Axonics Inc. (AXNX)|Enterprise Value BIOL (Biolase, Inc.)|Company Buyout Price Dynatronics Corp (DYNT)|FNA - Total Company Value|Full Business Value INVO